Eritrea vs Lithuania: Expected chances of death from non-communicable diseases, by gender
Eritrea
29.4%
in 2021
Lithuania
29.1%
in 2021
Eritrea rank
27th
Lithuania rank
29th
Expected chances of death from non-communicable diseases, by gender over time
- Eritrea
- Lithuania
How they compare
Eritrea currently reports 29.4% against 29.1% in Lithuania, a difference of 0.3%.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Eritrea ahead.
Eritrea ranks 27th and Lithuania ranks 29th of 185 countries.
Across the 3 decades both report, Eritrea averaged higher in 1 and Lithuania in 2.
Head to head by decade
| Decade | Eritrea | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.9% | 36.5% | 0.7% | Lithuania |
| 2010s | 31.8% | 32.1% | 0.3% | Lithuania |
| 2020s | 30.1% | 29.8% | 0.3% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, Eritrea or Lithuania?
- Eritrea, at 29.4% against 29.1% in Lithuania as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between Eritrea and Lithuania?
- 0.3%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Lithuania?
- 22 years are reported by both, from 2000 to 2021.
- How do Eritrea and Lithuania rank globally for expected chances of death from non-communicable diseases, by gender?
- Eritrea ranks 27th and Lithuania ranks 29th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.